Activating mutations in NOTCH1, an essential regulator of T cell development, are frequently found in human T cell acute lymphoblastic leukemia (T-ALL). Despite important advances in our understanding of Notch signal transduction, the regulation of Notch functions in the nucleus remains unclear. Using immunoaffinity purification, we identified NOTCH1 nuclear partners in T-ALL cells and showed that, beyond the well-characterized core activation complex (ICN1-CSL-MAML1), NOTCH1 assembles a multifunctional complex containing the transcription coactivator AF4p12, the PBAF nucleosome remodeling complex, and the histone demethylases LSD1 and PHF8 acting through their demethylase activity to promote epigenetic modifications at Notch-target genes. ...
Signaling pathways have evolved to ensure that external signals are sensed by a cell and translated ...
The Notch receptor is an evolutionarily highly conserved transmembrane protein essential to a wide s...
The pathways of NOTCH and PI3K/AKT are dysregulated in about 60% and 48% of T-cell acute lymphoblast...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological disease that arises from ...
Notch receptors participate in a conserved signaling pathway that controls the development of divers...
Notch signaling is a highly evolutionarily con-served pathway implicated in diverse functions includ...
Over the past decades, information has accumulated concerning the mechanism how an exterior signal i...
Activated Notch signaling is highly prevalent in T-cell acute lymphoblastic leukemia (T-ALL) and acc...
T cell lymphoblastic leukemia (T-ALL) is known to be associated with chromosomal abnormalities that ...
T cell acute lymphoblastic leukemia (T-ALL) is an immature hematopoietic malignancy driven mainly by...
<div><p>Notch is a major oncogenic driver in T cell acute lymphoblastic leukemia (T-ALL), in part be...
It is well established that Notch functions as a transcriptional activator through the formation of ...
Leukemia initiating cells (LIC) contribute to therapeutic resistance through acquisition of mutation...
The identification of activating mutations in NOTCH1 in over 50 % of T-cell acute lymphoblastic leuk...
Despite recent therapeutic improvements, Chronic Lymphocytic Leukemia (CLL) remains an incurable dis...
Signaling pathways have evolved to ensure that external signals are sensed by a cell and translated ...
The Notch receptor is an evolutionarily highly conserved transmembrane protein essential to a wide s...
The pathways of NOTCH and PI3K/AKT are dysregulated in about 60% and 48% of T-cell acute lymphoblast...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological disease that arises from ...
Notch receptors participate in a conserved signaling pathway that controls the development of divers...
Notch signaling is a highly evolutionarily con-served pathway implicated in diverse functions includ...
Over the past decades, information has accumulated concerning the mechanism how an exterior signal i...
Activated Notch signaling is highly prevalent in T-cell acute lymphoblastic leukemia (T-ALL) and acc...
T cell lymphoblastic leukemia (T-ALL) is known to be associated with chromosomal abnormalities that ...
T cell acute lymphoblastic leukemia (T-ALL) is an immature hematopoietic malignancy driven mainly by...
<div><p>Notch is a major oncogenic driver in T cell acute lymphoblastic leukemia (T-ALL), in part be...
It is well established that Notch functions as a transcriptional activator through the formation of ...
Leukemia initiating cells (LIC) contribute to therapeutic resistance through acquisition of mutation...
The identification of activating mutations in NOTCH1 in over 50 % of T-cell acute lymphoblastic leuk...
Despite recent therapeutic improvements, Chronic Lymphocytic Leukemia (CLL) remains an incurable dis...
Signaling pathways have evolved to ensure that external signals are sensed by a cell and translated ...
The Notch receptor is an evolutionarily highly conserved transmembrane protein essential to a wide s...
The pathways of NOTCH and PI3K/AKT are dysregulated in about 60% and 48% of T-cell acute lymphoblast...